Cross Country Poling Specific Motor Skill- and Strength Training. (CPMST)

September 21, 2021 updated by: University of South-Eastern Norway

Motor Skill- and Strength Training; Importance for Technique, Work Economy and Time Performance in Cross Country Poling

Will motor skill- and/or strength training affect technique, work economy and time performance in cross-country poling? Competitive cross-country skiers (age 16- 30) will perform a 10 weeks training intervention. They will be randomized in one of the following three groups: poling specific motor skill training 3 times per week in addition to their regular training, maximal strength training 3 times per week in addition to their regular training and a control group who only perform their regular training. Pre- and post intervention, all participants will perform tests in VO2max (running), VO2max (poling), work economy (poling), video and inertial measurement unit (IMU) analyzes of poling technique, time performance test (poling), motor skill tests and maximal strength tests.

Study Overview

Status

Status

Indicates the current recruitment status or the expanded access status.
Completed

Conditions

Conditions

The disease, disorder, syndrome, illness, or injury that is being studied. On ClinicalTrials.gov, conditions may also include other health-related issues, such as lifespan, quality of life, and health risks.

Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.

Detailed Description

Motor Skill- and Maximal Strength Training; Importance for Technique, Work Economy and Time Performance in Cross Country Poling Purpose The relative use of poling in classic cross-country skiing has increased over the last years. (Danielsen et al 2015). As a result of this poling performance has become increasingly important for over all classic cross-country skiing performance. Poling performance with best possible technical skills, implying high velocity with a least possible energy cost (C) should thus be beneficial. Previous research (Østerås et al 2002) has shown improved work economy in poling after maximal strength training (MST). To the investigators knowledge, the effect of motor skill training (MOT) on C has not previously been investigated. In this study MOT and MST will therefore be investigated (in two different groups of cross-country skiers), how they may affect poling technique, C, lactate threshold (LT) and poling performance. The results from this study may give further insight and knowledge in scientific based training practice.

The purpose of this study is thus to investigate if:

  1. MOT results in technical changes in poling?
  2. MST results in technical changes in poling?
  3. MOT improves C in poling?
  4. MST improves C in poling?
  5. changes in 1-4 improves time performance in poling?

In order to investigate this, competitive cross-country skiers (age 16- 30) will perform a 10 weeks training intervention. They will be randomized in one of the following three groups: poling specific motor skill training (10-12 x 3 repetitions maximum, RM) in specific designed cross country exercises 3 times per week in addition to their regular training. Further, maximal strength training in squat, dead lift, bench press, bench pull and pull down (2-5 x 3 repetitions RM) 3 times per week in addition to their regular training and a control group who only perform their regular training. Pre- and post intervention, all participants will perform tests in VO2max (running), VO2max (poling), work economy (poling), video and IMU analyzes of poling technique, time performance test (poling), motor skill tests and maximal strength tests.

Study Type

Study Type

Describes the nature of a clinical study. Study types include interventional studies (also called clinical trials), observational studies (including patient registries), and expanded access.
Interventional

Enrollment (Actual)

Enrollment

The number of participants in a clinical study. The "anticipated" enrollment is the target number of participants that the researchers need for the study.
45

Phase

Phase

The stage of a clinical trial studying a drug or biological product, based on definitions developed by the U.S. Food and Drug Administration (FDA). The phase is based on the study's objective, the number of participants, and other characteristics. There are five phases: Early Phase 1 (formerly listed as Phase 0), Phase 1, Phase 2, Phase 3, and Phase 4. Not Applicable is used to describe trials without FDA-defined phases, including trials of devices or behavioral interventions.
  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Norway
    • Telemark
      • Bø, Telemark, Norway, 3800
        • Telemark UC

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Eligibility Criteria

The key requirements that people who want to participate in a clinical study must meet or the characteristics they must have. Eligibility criteria consist of both inclusion criteria (which are required for a person to participate in the study) and exclusion criteria (which prevent a person from participating). Types of eligibility criteria include whether a study accepts healthy volunteers, has age or age group requirements, or is limited by sex.

Ages Eligible for Study

16 years to 30 years (Child, Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • healthy, competitive cross country athletes 16-30 years old

Exclusion Criteria:

  • contraindications to maximal strength training and strength and endurance testing

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm

Participant Group / Arm

A group or subgroup of participants in a clinical trial that receives a specific intervention/treatment, or no intervention, according to the trial's protocol.
Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.
Experimental: Motor skill training
training intervention. Poling specific indoor motor skill exercises performed 3 times pr week for 10 weeks in addition to regular training
Other: training intervention, motor skill training
cross country specific motor skill strength training
Experimental: Maximal strength training
training intervention. Maximal strength exercises performed 3 times pr week for 10 weeks in addition to regular training
Other: training intervention, maximal strength training
general maximal strength training
Experimental: Control group
Only regular training
Other: control group
regular training

What is the study measuring?

Primary Outcome Measures

Primary Outcome Measures

In a clinical study's protocol, the planned outcome measure that is the most important for evaluating the effect of an intervention/treatment. Most clinical studies have one primary outcome measure, but some have more than one.
Outcome Measure
Measure Description
Time Frame
Time trial poling on a roller ski tarmac track
Time Frame: 10 weeks
Seconds used in a 6 km track.
10 weeks

Secondary Outcome Measures

Secondary Outcome Measures

In a clinical study's protocol, a planned outcome measure that is not as important as the primary outcome measure for evaluating the effect of an intervention but is still of interest. Most clinical studies have more than one secondary outcome measure.
Outcome Measure
Measure Description
Time Frame
Video analyzes of technique
Time Frame: 10 weeks
Joint angles. Unique outcome measure.
10 weeks
Analyzes of angular velocity by use of IMU (inertial movement devices)
Time Frame: 10 weeks
Degree/second by use of gyrometer from the Musclelab System from Ergotest Technology. Unique outcome measure.
10 weeks
Analyzes of external force (N) in poles during poling
Time Frame: 10 weeks
Force measurements by use of the Musclelab System from Ergotest Technology. Unique outcome measure.
10 weeks
Maximal pulldown strength (RM/kg)
Time Frame: 10 weeks
Kilos in pulldown. Unique outcome measure.
10 weeks
Maximal leggpress strength (RM/kg)
Time Frame: 10 weeks
Kilos in leggpress. Unique outcome measure.
10 weeks
Maximal pulldown power (Watt)
Time Frame: 10 weeks
Watts in pulldown by use of Musclelab.System (Ergotest Technology). Unique outcome measure.
10 weeks
Maximal leggpress power (Watt)
Time Frame: 10 weeks
Watts in leggpress by use of Musclelab.System (Ergotest Technology). Unique outcome measure.
10 weeks
Maximal oxygen uptake (VO2max, ml/kg/min) in running on treadmill
Time Frame: 10 weeks
Ergospirometrical incremental (ramp) protocols using Cortex Metalyzer. Unique outcome measure.
10 weeks
Maximal oxygen uptake (VO2max, ml/kg/min) in poling on treadmill
Time Frame: 10 weeks
Ergospirometrical incremental (ramp) protocols using Cortex Metalyzer. Unique outcome measure.
10 weeks
Lactate threshold (mmol/L blood) in poling on treadmill
Time Frame: 10 weeks
Measurement of lactate using Lactate Scout (EKF Diagnostics) in different submaximal work periods up to the point reaching warm up values plus 2,3 mmol/L. Unique outcome measure.
10 weeks
Poling economy
Time Frame: 10 weeks
Measurement of oxygen consumption per meter poling. Unique outcome measure.
10 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Sponsor

The organization or person who initiates the study and who has authority and control over the study.
University of South-Eastern Norway

Collaborators

Collaborators

An organization other than the sponsor that provides support for a clinical study. This support may include activities related to funding, design, implementation, data analysis, or reporting.
The Norwegian Olympic Sports Center (Olympiatoppen)

Investigators

Investigators

A researcher involved in a clinical study. Related terms include site principal investigator, site sub-investigator, study chair, study director, and study principal investigator.
  • Principal Investigator: Arnstein Sunde, MSC, Telemark UC
  • Study Chair: Øyvind Støren, PhD, Telemark UC

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

Study Start

The actual date on which the first participant was enrolled in a clinical study. The "anticipated" study start date is the date that the researchers think will be the study start date.
June 20, 2017

Primary Completion (Actual)

Primary Completion

The date on which the last participant in a clinical study was examined or received an intervention to collect final data for the primary outcome measure. Whether the clinical study ended according to the protocol or was terminated does not affect this date. For clinical studies with more than one primary outcome measure with different completion dates, this term refers to the date on which data collection is completed for all the primary outcome measures. The "anticipated" primary completion date is the date that the researchers think will be the primary completion date for the study.
April 1, 2019

Study Completion (Actual)

Study Completion

The date on which the last participant in a clinical study was examined or received an intervention/treatment to collect final data for the primary outcome measures, secondary outcome measures, and adverse events (that is, the last participant's last visit). The "anticipated" study completion date is the date that the researchers think will be the study completion date.
July 1, 2019

Study Registration Dates

First Submitted

First Submitted

The date on which the study sponsor or investigator first submitted a study record to ClinicalTrials.gov. There is typically a delay of a few days between the first submitted date and the record's availability on ClinicalTrials.gov (the first posted date).
May 30, 2016

First Submitted That Met QC Criteria

First Submitted That Met QC Criteria

The date on which the study sponsor or investigator first submits a study record that is consistent with National Library of Medicine (NLM) quality control (QC) review criteria. The sponsor or investigator may need to revise and submit a study record one or more times before NLM's QC review criteria are met. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
March 7, 2017

First Posted (Actual)

First Posted

The date on which the study record was first available on ClinicalTrials.gov after National Library of Medicine (NLM) quality control (QC) review has concluded. There is typically a delay of a few days between the date the study sponsor or investigator submitted the study record and the first posted date.
March 13, 2017

Study Record Updates

Last Update Posted (Actual)

Last Update Posted

The most recent date on which changes to a study record were made available on ClinicalTrials.gov. There may be a delay between when the changes were submitted to ClinicalTrials.gov by the study's sponsor or investigator (the last update submitted date) and the last update posted date.
September 27, 2021

Last Update Submitted That Met QC Criteria

Last Update Submitted That Met QC Criteria

The most recent date on which the study sponsor or investigator submitted changes to a study record that are consistent with National Library of Medicine (NLM) quality control (QC) review criteria. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
September 21, 2021

Last Verified

Last Verified

The most recent date on which the study sponsor or investigator confirmed the information about a clinical study on ClinicalTrials.gov as accurate and current. If a study with a recruitment status of recruiting; not yet recruiting; or active, not recruiting has not been confirmed within the past 2 years, the study's recruitment status is shown as unknown.
May 1, 2017

More Information

Terms related to this study

Keywords

Other Study ID Numbers

Other Study ID Numbers

Identifiers or ID numbers other than the NCT number that are assigned to a clinical study by the study's sponsor, funders, or others. These numbers may include unique identifiers from other trial registries and National Institutes of Health grant numbers.
  • CPMST

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

planned published in a peer reviewed journal

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Healthy

Clinical Trials on training intervention, motor skill training

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Cookie Settings

We use cookies to ensure that we give you the best experience on our website. For more details carefully read our Privacy and Cookies Policy. ...>>>You can change your preferences or withdraw your consent at any time by deleting the cookies from your website or computer as described in the policy. Please accept it and choose your preferences by ticking the corresponding boxes in the "Manage Settings" section below. Please carefully read our Terms of Service before you proceed with using any part of this website.
«Manage Settings